Alexander H. C. Rosenström: On neuroimmune mechanisms in chronic pain.
- Date
- 28 November 2026, 09:15
- Location
- Humanistiska teatern, Engelska parken, Thunbergsvägen 3C, Uppsala
- Type
- Thesis defence
- Thesis author
- Alexander H. C. Rosenström
- External reviewer
- Thiago M. Cunha
- Supervisors
- Eva Kosek, Kim Kultima
- Publication
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-597910
Abstract
There is a constant interaction between the nervous and immune systems that shapes physiological responses throughout the body. This thesis explores some compartmental neuroimmune interactions across peripheral, barrier and central interfaces. Moreover, it highlights current methodological limitations in the assessment of this interaction.
Papers I and IV demonstrate several upregulated proteins in the cerebrospinal fluid (CSF) of cohorts with degenerative disc disease, lumbar disc herniation and fibromyalgia compared to controls. In contrast, serum levels of proteins diverge: some proteins are upregulated in fibromyalgia but in degenerative disc disease and lumbar disc herniation (LDH) most are downregulated. Moreover, there are few differentially expressed proteins that correlate with reported pain. These include CCL11, CD5, IL8 and MMP-10 in the LDH cohort. In papers II and IV, correlation analyses are extended to two symptoms commonly associated with chronic pain, namely sleep disturbance and general fatigue. Notably, CCL25 correlated negatively with general fatigue, and there were no correlations between protein levels and sleep disturbance.
Paper III investigates the blood-brain barrier and concludes that fibromyalgia subjects have significantly higher albumin quotients than subjects from the other pain cohorts. This is especially true for the subgroup of fibromyalgia subjects with high levels of IgG binding to satellite glia cells (anti-SGC IgG) in the dorsal root ganglia: they exhibit an even higher albumin quotient (paper III) and an accompanying upward shift in protein expression (paper IV).
In sum, there is a compartment-specific dysregulation of proteins in all studied cohorts. Several proteins in the CSF are upregulated regardless of pain condition, and in fibromyalgia there is an association between anti-SGC IgG binding and blood-brain barrier permeability. Regardless of pain type, there are few protein-symptom correlations. This last notion raises the question whether our measurement methods and patient-reported outcome measures are properly physiologically aligned.
Neuroimmune alterations seem prevalent across chronic pain phenotypes, but require compartment-specific measurement tools and dynamic perturbation models to bridge the gap between cellular signalling and patient experience.